Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
āFrom the detail of the Italian DSM collaboration it looks like DSM either plan to develop a rival product or are about to make a move. ā. .Good luck with that , after having ff for 14 years they still canāt sell f all .
Also note the change of wording ātotal projected annual sales value of the prospective sales pipeline for Fruitflow, which is now shared across Provexis and DSM, continues to stand at a substantial multiple of existing annual sales.ā hopefully DSM might be fully behind this now !
If I can make it to the AGM this year I have questions about funding 1/Ian why has it taken so long to address the funding issue ? Are you having problems ? 2/ this has been hanging over the heads of loyal shareholders for far too long a simple open offer could have sorted this a year ago why has this not happened .
Alfista , can you give me your opinion of this statement from the finals ..āĀ· The customer transfer process from DSM to Provexis has progressed well, and it saw initial sales of Ā£74k in the quarter ended 31 March 2023, following the inventory transfer in February. Sales in excess of Ā£280k have been made post year end, confirmed sales orders in excess of Ā£155k are currently being processed and the Company is dealing with numerous sales enquiries from existing and new customers for further direct sales of Fruitflow in 2023 and beyond.ā. . .. at first glance it looks encouraging Ā£280k H1 and Ā£155k for H2 ... but you can look at it as Ā£280k income of which Ā£155k is being processed . A bit concerning if that is the case . Imo
Revenue .the Ā£74,239. Will be Ā£280k + Ā£155k I think!
Fruitflow II SD ingredient - from 1 January 2023
74,239
-
DSM Alliance Agreement - up to 31 December 2022
170,269
281,899
Fruitflow+ Omega 3
145,408
144,269
389,916
426,168
Gixer sorry I was referring to the gut microbiome which DSM are fastracking to market apparently ! Anyway letās hope some answers are in the report tomorrow and as alfista has said donāt expect any news on funding as it has been a great tool to keep a cap on the sp for a year now , I might be a bit cynical but it has been frustrating .
Iām not expecting anything that will move the sp , more cut & paste and hopeful link ups with mysterious 3rd parties I expect . The ā Newā function claim will be talked about even though itās 15 months old now . Nothing happens with any pace at pxs Iām afraid . I hold in hope though!
I would think BH must have an order in now they have submitted their application to Samr . From the update in April . The Company will be in a better position to judge how best to manage its future inventory requirements (which can be met from either: (i) DSM's existing Fruitflow inventory; or (ii) a new Fruitflow production run) in the coming weeks once it has a clearer picture of: (i) the likely demand from the Company's actual and prospective Fruitflow customers for the next 12 months and beyond, to include By-Health
I didnāt know exactly what this relates to so I looked it up . Very interesting!..........Ischemia-reperfusion injury is a common feature of ischemic stroke, which occurs when blood supply is restored after a period of ischemia. Reperfusion can be achieved either by thrombolysis using thrombolytic reagents such as tissue plasminogen activator (tPA), or through mechanical removal of thrombi. Spontaneous reperfusion also occurs after ischemic stroke.